Suchergebnisse - "Hamada, Kensuke"

PubPharm (34)

1

THBS1-producing tumor-infiltrating monocyte-like cells contribute to immunosuppression and metastasis in colorectal cancer

enthalten in: Nature communications | 2023

von Omatsu, M. | Nakanishi, Y. | Iwane, K. | +40

2

Waning cellular immune responses and predictive factors in maintaining cellular immunity against SARS-CoV-2 six months after BNT162b2 mRNA vaccination

enthalten in: Scientific reports | 2023

von Ishii, T. | Hamada, K. | Jubishi, D. | +14

3

Differential involvement of LUBAC-mediated linear ubiquitination in intestinal epithelial cells and macrophages during intestinal inflammation

enthalten in: The Journal of pathology | 2023

von Sakamoto, Y. | Sasaki, K. | Omatsu, M. | +7

4

The association between adverse reactions and immune response against SARS-CoV-2 spike protein after vaccination with BNT162b2 among healthcare workers in a single healthcare system : a prospective observational cohort study

enthalten in: Human vaccines & immunotherapeutics | 2022

von Jubishi, D. | Okamoto, K. | Hamada, K. | +12

5

Enhanced Cytotoxicity on Cancer Cells by Combinational Treatment of PARP Inhibitor and 5-Azadeoxycytidine Accompanying Distinct Transcriptional Profiles

enthalten in: Cancers | 2022

von Araki, T. | Hamada, K. | Myat, A. | +7

6

May-Thurner Syndrome in a Patient With Ulcerative Colitis Complicated by Coronavirus Disease 2019

enthalten in: The American journal of gastroenterology | 2022

von Hamada, K. | Mankawa, N. | Yamamoto, S.

7

Primary Hepatic Mucosa-Associated Lymphoid Tissue Lymphoma in a Patient with Primary Biliary Cholangitis

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Hamada, K. | Yamamoto, S. | Seno, H.

8

Interpretations of SARS-CoV-2 IgM and IgG antibody titers in the seroepidemiological study of asymptomatic healthy volunteers

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2022

von Mitani, A. | Horie, T. | Yokoyama, R. | +18

9

A first-in-human phase I study of TAS0728, an oral covalent binding inhibitor of HER2, in patients with advanced solid tumors with HER2 or HER3 aberrations

enthalten in: Investigational new drugs | 2021

von Piha-Paul, S. | Azaro, A. | Arkenau, H. | +8

10

A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Saif, M. | Becerra, C. | Fakih, M. | +14